🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Poly(ADP-ribose) polymerase (PARP) inhibitors are anti-cancer treatments th...
Status
Recruiting
Location
Centre Hospitalier Universitaire d'Amiens Picardie Site Sud
Start Date
2024-09-24
Trial ID
NCT06572735
Treatments Being Tested
Clinical efficacy and tolerability for allergen specific immunotherapy (AIT...
Status
Completed
Location
Karolinska University Hospital
Start Date
2023-02-01
Trial ID
NCT06085963
Treatments Being Tested
Pharmacogenetics is an area of Pharmacology that studies the contribution o...
Status
Completed
Location
Multiple Locations
Start Date
2012-10
Trial ID
NCT02450487
Treatments Being Tested
The purpose of this study is to treat with traditional Chinese medicine mou...
Status
Completed
Location
Lo-Sheng Sanatorium
Start Date
2021-10-01
Trial ID
NCT05091216
This study aims to evaluate ergonomic risks among bank office employees and...
Status
Completed
Location
Uskudar University, Faculty of Health Sciences
Start Date
2025-11-24
Trial ID
NCT07481838
Treatments Being Tested
The aims of this research project are to evaluate whether global olfactory ...
Status
Completed
Location
Cliniques universitaires Saint-Luc
Start Date
2021-03-01
Trial ID
NCT04761458
The purpose of the two RCT registered here is to determine whether clinicia...
Status
Completed
Location
Kibwezi subCounty Hospital
Start Date
2014-09
Trial ID
NCT02388243
This research study is evaluating the reactivation of BK virus in patients ...
Status
Completed
Location
Dana-Farber Cancer Institute
Start Date
2018-07-30
Trial ID
NCT03532971
Treatments Being Tested
The goal of this clinical trial is to learn whether a Mindfulness-Based Eat...
Status
Recruiting
Location
University of New Brunswick
Start Date
2025-09-30
Trial ID
NCT07282964
This is a phase II Randomized comparison clinical trial of activated CIK ar...
Status
Withdrawn
Location
Institutional Review Board of Guangzhou Fuda Cancer Hospital
Start Date
2018-04-10
Trial ID
NCT03540199
Treatments Being Tested